Stock MIST MILESTONE PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Milestone Pharmaceuticals Inc.

Equities

MIST

CA59935V1076

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
1.57 USD +1.95% Intraday chart for Milestone Pharmaceuticals Inc. -3.68% -5.99%
Apr. 08 Milestone Pharmaceuticals Announces Etripamil Data Demonstrating Patients? Ability to Self-Manage Recurring PSVT, Presented at The American College of Cardiology Annual Meeting CI
Mar. 28 Milestone Pharmaceuticals Resubmits Etripamil New Drug Application to FDA MT

Business Summary

Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia (PSVT) with a subsequent indication to treat atrial fibrillation with rapid ventricular rate (AFib-RVR) and other cardiovascular indications.

Number of employees: 47

Sales per Business

USD in Million2022Weight2023Weight Delta
Cardiovascular Medicines
100.0 %
5 100.0 % 1 100.0 % -80.00%

Sales per region

USD in Million2022Weight2023Weight Delta
Canada
100.0 %
5 100.0 % 1 100.0 % -80.00%

Managers

Managers TitleAgeSince
Joseph Oliveto CEO
 Chief Executive Officer 56 17-03-06
Amit Hasija DFI
 Director of Finance/CFO 51 19-09-08
Anita Holz CTO
 Chief Tech/Sci/R&D Officer - 22-07-31
Debbie K. Everidge CTO
 Chief Tech/Sci/R&D Officer - 21-10-31
David Bharucha CTO
 Chief Tech/Sci/R&D Officer 62 22-02-14
Jeff Nelson COO
 Chief Operating Officer 42 20-05-31
Kimberly Sheehan HRO
 Human Resources Officer - 22-03-31
Roshan Girglani SAM
 Sales & Marketing - 22-07-31
Lorenz Muller PRN
 Corporate Officer/Principal 60 17-09-30
Guy Rousseau LAW
 General Counsel - 15-12-31

Members of the board

Members of the board TitleAgeSince
Seth Fischer BRD
 Director/Board Member 68 23-03-20
Joseph Oliveto CEO
 Chief Executive Officer 56 17-03-06
Debra Liebert BRD
 Director/Board Member 67 15-05-31
Richard Pasternak BRD
 Director/Board Member 75 19-11-10
Michael Tomsicek BRD
 Director/Board Member 58 19-03-31
Lisa Giles BRD
 Director/Board Member 65 20-09-30
Robert Wills CHM
 Chairman 70 20-09-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 53,149,778 52,815,928 ( 99.37 %) 0 99.37 %

Shareholders

NameEquities%Valuation
BlackRock Advisors LLC
6.154 %
3,270,749 6.154 % 6 M $
RTW Investments LP
6.126 %
3,256,102 6.126 % 6 M $
Alta Fundamental Advisers LLC
3.144 %
1,671,289 3.144 % 3 M $
Lion Point Capital LP
3.105 %
1,650,207 3.105 % 3 M $
Millennium Management LLC
2.812 %
1,494,489 2.812 % 3 M $
Goldman Sachs & Co. LLC
2.546 %
1,353,067 2.546 % 2 M $
Bleichroeder LP
2.495 %
1,326,085 2.495 % 2 M $
Venrock Associates
1.740 %
925,048 1.740 % 2 M $
Morgan Stanley Capital Services LLC
1.297 %
689,400 1.297 % 1 M $
BML Capital Management LLC
1.140 %
606,145 1.140 % 1 M $

Company contact information

Milestone Pharmaceuticals, Inc.

1111 Dr. Frederik-Philips Boulevard Suite 420

H4M 2X6, Montréal

+

http://www.milestonepharma.com
address Milestone Pharmaceuticals Inc.(MIST)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
1.57 USD
Average target price
10.5 USD
Spread / Average Target
+568.79%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
MILESTONE PHARMACEUTICALS INC. Stock Milestone Pharmaceuticals Inc.
-5.99% 96.6M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.63% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+1.62% 95.28B
ARGENX SE Stock argenx SE
+1.46% 22.15B
BIONTECH SE Stock BioNTech SE
-16.67% 21.02B
GENMAB A/S Stock Genmab A/S
-8.58% 18.15B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-38.74% 16.73B
BEIGENE, LTD. Stock BeiGene, Ltd.
-13.21% 16.05B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+5.41% 13.68B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+33.57% 12.17B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. MIST Stock
  4. Company Milestone Pharmaceuticals Inc.